Suspended
Collection of Cerebrospinal Fluid in Healthy Children
What is being collected
Data Collection
Collected at a single point in time - Cross-sectionalOtherNo DNA Sample
Who is being recruted
Lipid Metabolism, Inborn Errors+9
+ Lipidoses
+ Metabolic Diseases
From 2 to 8 Years
+4 Eligibility Criteria
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: December 2011
Summary
Principal SponsorWeill Medical College of Cornell University
Last updated: May 4, 2016
Sourced from a government-validated database.Claim as a partner
Study start date: December 1, 2011
Actual date on which the first participant was enrolled.obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.
Principal SponsorWeill Medical College of Cornell University
Last updated: May 4, 2016
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 2 to 8 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Lipid Metabolism, Inborn ErrorsLipidosesMetabolic DiseasesMetabolism, Inborn ErrorsCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System DiseasesNutritional and Metabolic DiseasesNeurodegenerative DiseasesHeredodegenerative Disorders, Nervous SystemGenetic Diseases, InbornLipid Metabolism DisordersNeuronal Ceroid-Lipofuscinoses
Criteria
2 inclusion criteria required to participate
Children already undergoing a lumbar puncture procedure for clinical or diagnostic purposes
Males and females, ages 2 yrs to 8 yrs
2 exclusion criteria prevent from participating
Presence of any significant medical conditions including cancer
Presence of any significant neurological diseases, as judged by the co-investigators
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Weill Cornell Medical College / New York Presbyterian Hospital
New York, United StatesOpen Weill Cornell Medical College / New York Presbyterian Hospital in Google MapsSuspendedOne Study Center